Rajkumar Ganesan | Executive Director - Oncology
Amgen Inc

As an Executive Director at Amgen’s Oncology research, Raj is engaged in discovery and pre-clinical development of Antibody Drug Conjugates and T cell engagers. He received PhD in Molecular Biology from University of Zurich. Over the last 15+ years, while working for Genentech, AstraZeneca, Boehringer Ingelheim and Janssen, Raj has led the discovery efforts for several molecular and cellular therapies and progressed series of Immunotherapeutics and CAR Ts for clinical development.